Medical Equipment

Platelet Aggregation Devices Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

March 16, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Platelet Aggregation Devices Market Expected To Change Between 2026 And 2030?

The market for platelet aggregation devices has shown significant expansion in recent years. This sector is projected to increase from $1.04 billion in 2025 to $1.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 25.4%. Historically, this growth can be ascribed to several factors, including growth in cardiovascular disease prevalence, expansion of clinical diagnostic laboratories, increasing use of antiplatelet therapies, rising demand for coagulation testing, and advancements in hematology diagnostics.

The platelet aggregation devices market size is anticipated to experience substantial expansion over the next few years. It is projected to achieve a value of $2.94 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 22.5%. This growth throughout the forecast period stems from the increasing adoption of personalized medicine, greater investments in advanced diagnostics, a rising requirement for rapid platelet function testing, an increase in research concerning blood disorders, and ongoing innovations in diagnostic technologies. Significant trends during the forecast period include the expanding use of automated platelet function analyzers, a growing need for high-throughput testing systems, increasing integration of digital data management, the proliferation of multi-channel aggregation devices, and an intensified focus on diagnostic accuracy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

What Underlying Factors Are Accelerating The Growth Of The Platelet Aggregation Devices Market?

The rising occurrence of target diseases is projected to propel the platelet aggregation devices market forward. Target diseases are specific health conditions, such as cancer, cardiovascular diseases, and diabetes, which receive focused prevention, diagnosis, and treatment efforts due to their substantial public health impact. Platelet aggregation devices contribute to reducing the incidence of these target diseases by enabling early detection and effective management of thrombotic risks, thereby preventing complications like heart attacks and strokes among susceptible populations. For example, in February 2024, data released by the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), revealed that the world experienced approximately 20 million new cancer cases and 9.7 million deaths in 2022. Projections indicate a 77% increase to over 35 million new cases by 2050. Lung cancer was the most common globally with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Therefore, the increasing prevalence of target diseases is driving the expansion of the platelet aggregation devices market.

How Is The Platelet Aggregation Devices Market Structured Across Different Segments?

The platelet aggregation devices market covered in this report is segmented –

1) By Product: Reagents, Systems, Consumables And Accessories

2) By Channel Configuration: Four Channel, Dual Channel, Eight Channel

3) By Technology: Optical, Impedance, Other Technologies

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Other Applications

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

Which Trends Are Shaping The Future Of The Platelet Aggregation Devices Market?

Leading companies within the platelet aggregation devices market are intensifying their efforts to develop advanced solutions, notably by introducing innovative products such as the inaugural platelet pooling set, designed to help stabilize the U.S. platelet supply and meet increasing requirements. A platelet pooling set is a specialized medical instrument utilized in plateletpheresis procedures to gather and concentrate platelets from multiple donors into a single unit for transfusion therapy. For example, in February 2023, Terumo BCT Inc., a US-based company specializing in blood components and cellular technology, announced the approval of its IMUGARD WB Platelet Pooling Set by the Food and Drug Administration (FDA), a US-based federal agency. This innovation offers an extended shelf life for platelets, with FDA clearance for seven-day storage, and enables the recovery of platelets from whole blood donations, thereby enhancing flexibility and availability in the platelet aggregation devices market. This product launch signifies a considerable technological advancement by addressing the demand for improved platelet availability, more efficient supply management, and supporting the strained U.S. platelet supply to fulfill increasing needs in critical medical procedures like chemotherapy and organ transplants.

Which Major Players Dominate The Platelet Aggregation Devices Market?

Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG And Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago, Instrumentation Laboratory

Read the full platelet aggregation devices market report here:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

Which Region Is Projected To Dominate The Platelet Aggregation Devices Market During The Forecast Period?

North America was the largest region in the platelet aggregation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Platelet Aggregation Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Browse Through More Reports Similar to the Global Platelet Aggregation Devices Market 2026, By The Business Research Company

Platelet Rich Plasma Market Report 2026

https://www.thebusinessresearchcompany.com/report/platelet-rich-plasma-global-market-report

Platelet Shaker Market Report 2026

https://www.thebusinessresearchcompany.com/report/platelet-shaker-global-market-report

Thrombectomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/thrombectomy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795